Novo Nordisk | NVO - Market Capitalization


Novo Nordisk reported DKK145.72B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ANI Pharmaceuticals USD 1.88B 133M Jun/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
Bausch Health Companies USD 2.61B 200M Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Canopy Growth CAD 557.13M 99.33M Mar/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Drreddys Laboratories INR 11.07B 619M Mar/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Novo Nordisk DKK 212.17B 55.02B Jun/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Pacira USD 998M 83M Jun/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.24B 566M Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Supernus Pharmaceuticals USD 2.7B 277M Jun/2026
Zoetis USD 30.13B 19.58B Jun/2026